Register Today
April 8–10, 2019
Boston, MA • United States

2018 Agenda

PLEASE NOTE: The content on this page refers to last year’s sold out event.

We are in the planning stages for the 2019 event on April 8–10 and expect to release new information in early to late fall of 2018. Please contact us if you have specific questions.

Monday, April 23, 2018

7:00 am - 8:00 am
GE Foyer
7:00 am - 8:00 am
Nuance Foyer
8:00 am - 11:30 am
NVIDIA Ballroom
First Look: The Next Wave of AI Breakthroughs in Health Care

Early career Harvard Medical School investigators kick-off the 2018 World Medical Innovation Forum with rapid fire presentations of their high potential new technologies. Nineteen rising stars from Brigham Health and Massachusetts General Hospital will give ten-minute presentations highlighting their discoveries and insights that will disrupt the field of artificial intelligence. This session is designed for investors, leaders, donors, entrepreneurs and investigators and others who share a passion for identifying emerging high-impact technologies. To view speakers and topics, click here.

Moderator: Trung Do
  • VP, Business Development, Innovation, PHS
  • Vice Chair of Research at the Department of Radiology, BWH; Ferenc Jolesz MD Professor of Radiology, HMS
11:45 am - 1:00 pm
3rd Floor and 7th Floor
Discovery Café Workshops

Lunch with Top Leadership from across Partners HealthCare and Industry.

Seven intensive workshops addressing cutting-edge artificial intelligence topics. To view topics and speakers, click here

1:00 pm - 1:20 pm
1:20 pm - 1:45 pm
NVIDIA Ballroom
Opening Remarks
  • Governor of the Commonwealth of Massachusetts
  • Chief Academic Officer, PHS; Laurie Carrol Guthart Professor of Medicine, Academic Dean for Partners, HMS; 2018 Forum Co-Chair
  • CEO, PHS
1:45 pm - 2:25 pm
NVIDIA Ballroom
Reflecting on the Impact of AI at the Bed and the Bench: Chairs Roundtable

Senior clinical leaders, current and past Forum Chairs, will share perspectives on the range of impact of AI on clinical practice. Discussion will highlight the rapid evolution of AI as a practical clinical tool and short and mid-term prospects for adoption in cancer, cardiovascular and neurological care.

Moderator: Sue Siegel
  • CIO and CEO, Business Innovations, GE
  • Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
  • Chief Academic Officer, PHS; Laurie Carrol Guthart Professor of Medicine, Academic Dean for Partners, HMS; 2018 Forum Co-Chair
  • Vice Chair for Scientific Innovation, Department of Medicine, BWH; Chief Executive, One Brave Idea, BWH; Associate Professor of Medicine, HMS; 2017 Forum Co-Chair
  • Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2018 Forum Co-Chair
  • Chief, Cardiology Division, MGH; Professor of Medicine, HMS; 2017 Forum Co-Chair
2:25 pm - 3:15 pm
NVIDIA Ballroom
Can AI Based Drug Development Feed A Hungry Pipeline?

Given the scarcity of late-stage assets, prolonged timelines and enormous costs of bringing drugs to market, AI-based approaches to target discovery, drug design and drug repurposing hold significant promise to positively disrupt the existing R&D paradigm.

  • Chief Data Officer, Broad Institute; Cardiologist, BWH; Venture Partner, Google Ventures
  • CEO, Exscientia
  • Director, Center for Genomic Medicine, MGH; Ofer and Shelly Nemirovsky MGH Research Scholar; Associate Professor of Medicine, HMS
  • EVP and CSO, R&D, Bristol-Myers Squibb
  • SVP, Strategy, Commercialization & Innovation, Amgen
3:15 pm - 4:05 pm
NVIDIA Ballroom
Smart EHRs: AI for All

The first wave of EHR adoption has focused primarily on digitizing the patient record – with a more recent focus on building interactive clinical decision support capabilities. Development and implementation of CDS applications currently  requires  clinical staff to observe trends in data, develop protocols to act on these trends and work with technical staff to codify the logic into executable form. As NLP and computer vision capabilities become more advanced, algorithms will identify and propose actions reflecting patterns in the data. The panel will discuss existing challenges and whether AI technology will ultimately support an unsupervised learning approach in the EHR to identify trends and possible responses at both the patient and population level?

  • SVP and CMO, MGH
  • CEO, Health Catalyst
  • Director, Analytics & Machine Learning, Epic
  • President, Digital, Persistent Systems
  • CEO, Picnic Health
  • CEO, Wolters Kluwer Health
4:05 pm - 4:55 pm
NVIDIA Ballroom
AI and the Cost of Trials: The Impact of Real World and Real Time Evidence

AI based approaches to conduct faster and more efficient clinical trials are beginning to emerge. Current approaches include applying predictive tools to perform more targeted patient recruitment and more accurate eligibility assessment. Panelists will discuss timelines for AI technology to have a measurable effect on trial cost and time to conduct the trial. Bottlenecks to applying this technology at scale and whether there will be a measurable effect on the cost of bringing drugs to market over the next decade will also be examined.

  • Partner, Google Ventures; Instructor in Medicine, BWH
  • CMO, CSO & SVP Oncology, Flatiron Health
  • VP, Research IT, Eli Lilly and Company
  • CEO, GNS Healthcare
  • CEO, BenevolentAI
  • Senior Advisor, R&D, Bayer
  • Executive Director, Clinical Trials Office, PHS; Associate Professor of Medicine, HMS
5:00 pm - 6:00 pm
Nuance Foyer

Tuesday, April 24, 2018

7:15 am - 7:50 am
Nuance Foyer
7:50 am - 8:00 am
NVIDIA Ballroom
Opening Remarks
  • Chief Innovation Officer, PHS; President, Partners HealthCare International, PHS
8:00 am - 8:50 am
NVIDIA Ballroom
Will AI Bend the Cost and Access Curve

Historical barriers have driven increased medical costs and decreasing access since the 1960s. The “Iron Triangle of Healthcare” continues to represent a tenuous balance of quality, cost and accessibility – economists have lamented attempts to optimize one characteristic at the expense of the others. The accumulation of innovations in care delivery (e.g. shift to lower cost providers and settings), population management, value based reimbursement and hospital administration are having a measurable effect. Can AI based technologies accelerate the pace of innovation and finally bend the cost and access curves in the US?

  • SVP and CMO, Humana
  • CEO, Cyft, Inc.
  • Vice Chairman, Investment Banking and Managing Director, Lazard Freres
8:50 am - 9:40 am
NVIDIA Ballroom
Drug Therapy Redefined Through Machine Learning

The drug development process is highly complex and has many drivers. The panel will discuss the strategic impact of AI on the entire process and the implications for healthcare overall. How will the combination of factors – research strategy, drug development, regulatory approvals, reimbursement and clinical effectiveness – be influenced by the implementation of AI. Panelists will discuss short and mid-term prospects and whether AI will ultimately lead to a restructuring of the pharma model to develop new therapies.

  • Partner, Atlas Venture
  • President, Novartis Institutes for Biomedical Research
  • Senior Director, Digital and Personalized Health Care Partnering, Roche
  • CSO, Relay Therapeutics
  • SVP, Global Head of Data Sciences, Johnson & Johnson
  • CSO, Datavant
9:40 am - 10:10 am
NVIDIA Ballroom
1:1 Fireside Chat: Atul Gawande, MD
Introduction by: John Fish
  • CEO, Suffolk; Chairman of Board Trustees, Brigham Health
  • President, Brigham Health; Professor of Medicine, HMS
  • Executive Director, Ariadne Labs; Samuel O. Thier Professor of Surgery, HMS; Surgeon, BWH
10:10 am - 10:25 am
Nuance Foyer
10:25 am - 11:15 am
NVIDIA Ballroom
Data Engineering in Healthcare: Liberating Value

The promise of machine learning and big data in in healthcare seems boundless – but healthcare data is massive and complex, and organizing and managing this data is the first step to an AI-empowered healthcare system.  Technology giants are investing in solutions to overcome these data engineering challenges, but with many visions of the future of healthcare data jockeying for dominance, what will the future of healthcare data really look like?  Can we finally liberate the value of data for patient care? And how will it happen?

  • Executive Director, MGH & BWH CCDS
  • ‎Director of Healthcare Research, Microsoft Research
  • VP and Global CTO, Sales, Dell EMC
  • SVP and CMO, Qualcomm Life
  • VP, Healthcare, Google Cloud
  • Chief Research Information Officer, PHS; Associate Professor of Neurology, HMS
  • CTO, Cognitive Collaboration Group, Cisco
11:15 am - 11:45 am
NVIDIA Ballroom
1:1 Fireside Chat: Jensen Huang, CEO, NVIDIA
Introduction by: Scott Sperling
  • Co-President, Thomas H Lee Partners; Chairman of the Board of Directors, PHS
  • Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
12:00 pm - 1:00 pm
GE Ballroom
12:30 pm - 1:00 pm
GE Ballroom
1:1 Fireside Chat: Paul Ricci, Former Chairman and CEO of Nuance Communications
Introduction by: Cathy Minehan
  • Managing Director, Arlington Advisory Partners; Chairman, Board of Trustees, MGH
Moderator: James Brink, MD
  • Chief, Department of Radiology, MGH; Juan M. Taveras Professor of Radiology, HMS
  • Former Chairman and CEO, Nuance Communications
1:00 pm - 1:10 pm
1:10 pm - 2:00 pm
NVIDIA Ballroom
AI and Gene Sequencing

Gene sequencing technology has evolved considerably over the last 10 years, dramatically decreasing the cost to sequence a human genome. As the costs associated with the technical assay continue to decrease, data interpretation and reporting has become the new bottleneck. Can AI and ML based approaches be applied to better understand how genetic mutations play a role in diseases like cancer – where the high rate of mutation makes treatment challenging? And will continued democratization of genetic information help to accelerate the pace of innovation in the field?

Moderator: Heidi Rehm, PhD
  • Chief Laboratory Director, Laboratory for Molecular Medicine, PHS Personalized Medicine; Associate Professor of Pathology, BWH and HMS
  • Executive Director, Worldwide R&D, Pfizer
  • Director, Bioinformatics Program, Cancer Center and Department of Pathology, MGH; Director, Institute Member, Broad Institute; Associate Professor of Pathology, HMS
  • Director, Computational Pathology and Director, Technology Development, Center for Integrated Diagnostics, MGH; Assistant Professor, Pathology, HMS
  • CEO, Freenome
  • SVP, Product Development, Illumina, Inc.
2:00 pm - 2:50 pm
NVIDIA Ballroom
Tangible Returns on the AI Value Proposition

Fueled by billions in venture investments, hundreds of new companies have emerged worldwide to develop and apply AI in health care. Beyond the US, China’s high AI priority has resulted in a vast array of technology driven start-ups. Global investors will discuss which area of machine learning will have the earliest meaningful impact? How do investors critically assess differentiation in such a crowded field? How are investment priorities set among the many divergent categories where AI will take hold?

Moderator: Meg Tirrell
  • Reporter, CNBC
  • Managing Director, Santé Ventures
  • VP, Venture, Innovation, PHS
  • Partner, Polaris Partners
  • Partner, Andreessen Horowitz
  • Managing Director, Northern Light Venture Capital
2:50 pm - 3:40 pm
NVIDIA Ballroom
CEO Roundtable: The AI Opportunity as Foundational Change

Chief executives share perspectives on the impact of AI on their respective companies and industry segments. How prominently does AI figure into current investment strategies? And how are they measuring return on existing investments in AI? Panelist will be asked to take a position on whether AI is a truly transformational technology.

Moderator: Peter Slavin, MD
  • President, MGH
  • Chief Innovation Officer, GE Healthcare
  • CEO, Philips
  • CEO, Vertex
  • CEO, Siemens Healthineers
3:40 pm - 3:50 pm
NVIDIA Ballroom
Announcement of IDG Awardees
  • Chair, Department of Radiology, BWH; Philip H. Cook Professor of Radiology, HMS
  • Chief, Department of Radiology, MGH; Juan M. Taveras Professor of Radiology, HMS
3:50 pm - 4:40 pm
NVIDIA Ballroom
Regulating AI in Healthcare, Requirements and Challenges

The increasing application of AI in health products puts pressure on the historical model of regulation – among them the agile development cycles and continuous learning environment that support AI / machine learning based algorithms. Panelists will discuss the regulatory approaches including the FDA’s recently announced Software Precertification pilot program.

Moderator: Michael Jaff, DO
  • President, NWH, PHS, Professor of Medicine, HMS
  • CEO, Arterys
  • Chief Regulatory Officer, Sanofi
  • VP and GM, Healthcare Digital Solutions, GE Healthcare
  • Associate Director for Digital Health, FDA
4:40 pm - 5:30 pm
NVIDIA Ballroom
AI in Hospital Environments: The Learning Provider

Health systems are actively evaluating strategies to drive efficiency throughout hospital operations. The deployment of AI based technologies to automate organizational tasks (e.g. medical coding / billing, prior authorizations) and optimize resource utilization (e.g. smart scheduling, no-show prediction) promises to help hospital systems adapt to changing macro-economic factors. This panel will discuss the role of AI in hospital operations and assess various approaches to reduce healthcare administration costs and increase efficiency.

Moderator: Adam Landman, MD
  • VP and CIO, Brigham Health
  • Executive Director, IT, Personalized Medicine, PHS
  • Partner, Optum Ventures
  • CEO, Change Healthcare
  • CEO, Qventus
  • Co-Founder, Director, PokitDok
5:30 pm - 6:30 pm
GE Foyer

Wednesday, April 25, 2018

7:00 am - 7:30 am
Nuance Foyer
7:30 am - 8:20 am
NVIDIA Ballroom
Reconceiving Medical Devices in an AI Dominated Environment

Medical device companies are focused on developing smaller, faster and smarter devices. New technologies will enhance the function of medical devices throughout patient care. Leveraging AI technology to more effectively interact with patients and inform / facilitate outcomes enables smart devices that can learn and improve performance over time. The nature of AI panel based devices, the challenges inherent in developing them and how such devices can evolve over the next 5 years and beyond will be examined.

Moderator: Pat Fortune, PhD
  • VP, Market Sectors, Innovation, PHS
  • CEO, Bay Labs
  • SVP, Chief Medical and Scientific Officer, Medtronic
  • Founder and CEO, Butterfly Network
  • Associate Chief, Cardiology Division, MGH; Professor of Medicine, HMS
8:20 am - 8:50 am
NVIDIA Ballroom
Fireside Chat: Seema Verma, Administrator, Centers for Medicare and Medicaid Services
Moderator: Gregg Meyer, MD
  • Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2018 Forum Co-Chair
  • Administrator, Centers for Medicare and Medicaid Services
8:50 am - 9:20 am
NVIDIA Ballroom
Fireside Chat: Paying for AI: Thinking Strategically About Reimbursements and Acceptance

Understanding how AI will be absorbed into a highly defined payment system is crucial to determining the rate and breadth that the technology will play in health care in the next decade. Two senior leaders will share their perspectives on how the technology will be paid for and what mechanisms will be used to arbitrate the scope and timing of those payments.

Moderator: Peter Markell
  • EVP Administration and Finance, CFO and Treasurer, PHS
  • CEO, BCBS of North Carolina
  • CEO, OptumInsight & Enterprise Growth Officer, Optum
9:20 am - 9:50 am
NVIDIA Ballroom
1:1 Fireside Chat: Vasant Narasimhan, MD, CEO, Novartis
Moderator: Gregg Meyer, MD
  • Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2018 Forum Co-Chair
  • CEO, Novartis
9:50 am - 10:40 am
NVIDIA Ballroom
Machine Learning in Image Analysis: A Diagnostician’s Best Friend…or Replacement?

Diagnostic imaging is among the clinical fields receiving the greatest attention in the early stages of AI in healthcare. Even in this initial phase it appears that the technology may have profound effects on one of the most resource intensive fields in medicine. Panelists will consider the broad implications as well as topics such as how will role of radiologists evolve? Will AI tools ever become advanced enough to make decisions autonomously within the clinical workflow?

Moderator: Giles Boland, MD
  • Chair, Department of Radiology, BWH; Philip H. Cook Professor of Radiology, HMS
  • CEO, PathAI
  • VP, Medical Imaging Technology, Siemens Healthineers
  • Co-Founder and Chairman, Zebra Medical Vision
  • CEO, GE Healthcare Imaging
  • Chief, Breast Imaging Division, MGH; Professor of Radiology, HMS
10:40 am - 10:50 am
Nuance Foyer
10:50 am - 11:20 am
NVIDIA Ballroom
1:1 Fireside Chat: John Kelly, PhD, SVP, Cognitive Solutions and Research, IBM
Moderator: James Noga
  • VP and CIO, PHS
  • SVP, Cognitive Solutions and Research, IBM
11:20 am - 12:10 pm
NVIDIA Ballroom
Illuminating the Path to Clinician Empowerment

The sacred exchange between patient and clinician at the heart of medicine is increasingly under duress driven by a range of factors. Increasing clinician burnout is recognized as among the many negative consequences of this trend. Panelists will discuss how AI may improve the quality of the patient encounter, clinician workflow and ultimately clinician quality of life. Panelist will discuss how the new technology can meet these objectives when earlier information based technologies may have exacerbated the challenge.

  • VP, Population Health Management, PHS
  • SVP, New Business Development, Healthcare Division, Nuance
  • Chief Health Strategy Officer, US Health & Life Sciences, Microsoft
  • CEO, Robin AI
  • Chief Medical Information Officer, MGPO
12:10 pm - 1:10 pm
NVIDIA Ballroom
Disruptive Dozen: 12 AI Technologies That Will Reinvent Care

The culture of innovation throughout Partners HealthCare naturally fosters robust discussions about new “disruptive” technologies and which ones will have the biggest impact on health care. The Disruptive Dozen was created to identify and rank the technologies that Partners faculty feel will break through over the next decade to significantly improve health care. This year, the Disruptive Dozen focuses on relevant advances and opportunities in artificial intelligence (AI).

  • Director of Research Strategy and Operations, MGH & BWH CCDS; Associate Professor, Radiology, HMS
  • Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
1:10 pm - 1:15 pm
NVIDIA Ballroom
Last Look
  • Chief Data Science Officer, PHS; Vice Chairman, Radiology, MGH; Associate Professor, Radiology, HMS
  • Chief Academic Officer, PHS; Laurie Carrol Guthart Professor of Medicine, Academic Dean for Partners, HMS; 2018 Forum Co-Chair
  • Chief Clinical Officer, PHS; Professor of Medicine, HMS; 2018 Forum Co-Chair

*Panels and speakers are subject to change.